Sublocade

FDA Approves Once-Monthly Buprenorphine Injection for Opioid Use Disorder

FDA Approves Once-Monthly Buprenorphine Injection for Opioid Use Disorder

By

In a press release issued November 30, 2017, the US Food and Drug Administration announced it has approved Sublocade, a once-monthly buprenorphine injection for moderate to severe opioid use disorder.

Sign Up for Free e-Newsletters